Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03284034 · ClinicalTrials.gov registry record · NA
Cryolipolysis Versus ATX-101 (Deoxycholic Acid) for Upper Back Fat
A NA study, sponsored by Northwestern University.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT03284034 is a NA study that was terminated before completion, run by Northwestern University. The registered enrollment target is 8 participants.
The verdict
NCT03284034, a NA study, was terminated before completion, sponsored by Northwestern University.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
This is a prospective randomized controlled study comparing the efficacy of cryolipolysis versus ATX-101 (deoxycholic acid) for the treatment of upper back fat. Participants currently living in the Chicago metropolitan area and meet inclusion/exclusion criteria will be considered for enrollment. The treatment sites are the right and left upper back fat areas. The right and left sides of the upper back fat will be randomly assigned (1:1) to receive cryolipolysis, while the contralateral side will receive ATX-101. This study was a pilot study designed to determine feasibility of this procedure.
Interventions
- DRUG ATX-101
- DEVICE CoolCurve
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2017-11-27 |
| Est. Completion | 2020-06-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03284034
The ClinicalTrials.gov registry entry for NCT03284034 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ATX-101 is the first listed.
NCT03284034 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03284034 about?
NCT03284034 is a clinical study titled "Cryolipolysis Versus ATX-101 (Deoxycholic Acid) for Upper Back Fat". This is a prospective randomized controlled study comparing the efficacy of cryolipolysis versus ATX-101 (deoxycholic acid) for the treatment of upper back fat. Participants currently living in the Chicago metropolitan area and meet inclusion/exclusion criteria will be considered for enrollment. The...
What is the current status of trial NCT03284034?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2017-11-27. Estimated completion is 2020-06-08.
What interventions are being tested in trial NCT03284034?
The interventions under investigation include: ATX-101 (DRUG), CoolCurve (DEVICE).
Who is sponsoring clinical trial NCT03284034?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.